Table 1 Factors for selection of patients for AS achieving agreement after Round 1 questionnaire
PSA < 10 ng/mL |
Clinical stage < T2 |
Systematic and/or Targeted biopsy approach |
12 cores taken at biopsy |
Gleason score 3 + 4 or lower |
PSA < 10 ng/mL |
Clinical stage < T2 |
Systematic and/or Targeted biopsy approach |
12 cores taken at biopsy |
Gleason score 3 + 4 or lower |